Novateur Ventures

What Novateur Ventures does

Novateur Ventures Inc. is a privately held life sciences advisory and investment firm founded in 2015 and headquartered at 1055 West Georgia Street in Vancouver, British Columbia. The firm provides clinical translation, business development, due diligence, product development, regulatory strategy, and company creation services to biotechnology, pharmaceutical, medical device, and digital health companies globally. Novateur operates a deliberately lean core team of 1-10 people augmented by a network of more than 200 expert advisors with experience spanning over 80 approved drugs and devices, enabling bespoke, virtual team engagements delivered on a project basis. The firm is led by founder and Managing Director Ali Ardakani, who also serves as Chair of Life Sciences BC and CEO & Co-Founder of Optigo Biotherapeutics.

The firm's business model is built on fee-based professional services engagements supplemented by equity participation in select portfolio companies. Advisory services are priced on a custom, quote-based engagement model with multi-year contracts, and notable client engagements include supporting Daewoong Pharmaceutical's immunology assets through to a US$477 million global license with Vitalli Bio, Beyond Air's path from startup to NASDAQ listing with FDA PMA approval, and Sonic Incytes' 510(k) clearance within 50 days of submission. The investment arm has participated in company creation, including co-founding and seeding Epitopea in 2021-2022 (a $13.6M seed for a Université de Montréal/IRIC cancer therapeutics spin-out).

In parallel with advisory services, Novateur operates bioRSVP, a free mobile application (evolved from the original Guide to JPM app launched in 2019) co-branded with the Biotechnology Innovation Organization (BIO). The app provides satellite event listings, calendar integration, venue mapping, and networking coordination for premier life sciences conferences including the J.P. Morgan Healthcare Conference, having reached more than 8,000 users by 2023 with a target of 10,000+ for 2025. The company has earned two Life Sciences BC awards (Strategic Life Sciences Partner of the Year in 2021 and the Milton Wong Community Leadership Award in 2025), underscoring its standing in the British Columbia life sciences ecosystem.

Name

Novateur Ventures

Legal name

Novateur Ventures Inc.

Website

https://novateur.ca

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Novateur Ventures is a Vancouver-based life sciences advisory and investment firm providing due diligence, product development, business development, regulatory, and company creation services to biotech, pharma, medical device, and digital health clients globally, leveraging a 200+ advisor network and the bioRSVP conference networking app.

Ownership category

akta.pro rank

Product category

Life Sciences Advisory Services

NAICS

Management Consulting Services (54161), Portfolio Management and Investment Advice (523940), Other Scientific and Technical Consulting Services (54169), Scientific Research and Development Services (5417)

SIC

Services-Management Consulting Services (8742), Investment Advice (6282), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industry

Corporate M&A / Venture Build-to-Buy Programs (Acqui-hire, option-to-acquire) (FSANAHAG)

Keywords

• Life sciences advisory
• Pharmaceutical consulting
• Biotech business development
• Medical device regulatory
• Company creation services

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Advisory Services: Professional advisory services for life sciences companies including due diligence, product development, business development, company creation, and education. Delivered by virtual team of seasoned professionals.
2. Investment Returns: Equity investments in life sciences companies through participation in founding and financing companies such as Epitopea.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Novateur Ventures is a life sciences advisory and investment firm that delivers clinical translation and business development expertise to biotechnology, pharmaceutical, medical device, and digital health companies through a virtual team of over 200 expert advisors. Services span due diligence, product development, regulatory affairs, business development, and company creation. The firm also operates the bioRSVP mobile app (formerly Guide to JPM) that helps investors, operators, and innovators discover satellite events at premier life sciences conferences worldwide.

Product overview

Novateur Ventures offers a portfolio of advisory and investment services for the life sciences sector alongside their primary digital product, bioRSVP. Their service offerings include Due Diligence, Product Development, Business Development, Company Creation, and Novateur Academy education programs, serving biotechnology, pharmaceutical, medical device, and digital health companies. The bioRSVP mobile application (evolved from the original Guide to JPM) serves as their flagship digital product, providing event networking capabilities for the life sciences conference ecosystem. The company operates with over 200 advisors globally and has participated in company creation activities including co-founding Epitopea.

Differentiator

Problem solved

Functional benefit

Brands

• bioRSVP: Mobile app for life sciences conference networking, previously known as Guide to JPM. Supports the full calendar of premier life sciences conferences worldwide, designed for investors, operators, and innovators to stay connected across conferences, cities, and opportunities.
• Novateur Academy

Products and services

• bioRSVP Mobile App Free mobile app for investors, operators, and innovators in the life sciences ecosystem that provides comprehensive listings of satellite networking events at premier life sciences conferences including J.P. Morgan Healthcare Conference. Features event discovery, calendar integration, venue mapping, and networking coordination.
• Due Diligence Services Expert advisory services for evaluating investment opportunities, technology assessments, scientific due diligence, and comprehensive analysis of product candidates and market opportunities in the life sciences sector.
• Product Development Services Comprehensive support spanning preclinical through clinical stages including CMC review, formulation development, regulatory strategy, and vendor management for drug and device development programs.
• Business Development Services Strategic advisory for pipeline optimization, launch strategy, business plan development, investor pitches, corporate prospectus preparation, partnership negotiations, and licensing support across biopharmaceutical development pathways.
• Company Creation Services Full-spectrum support for launching new life sciences companies, including NPV modeling, market analyses, reimbursement strategies, technology commercialization, and company spin-out support from academic and industry sources.
• Novateur Academy Educational programs and masterclasses for life sciences professionals covering business development, licensing, IP strategy, deal structuring, and therapeutic company operations.

Quantifiable outcome

• Daewoong Pharmaceutical: Global License Agreement worth up to US$477 million with over US$10 million upfront
• +3 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered flagship, core and minor.

• Life Sciences BCflagshipStrategic or Co-development Partner · 1 January 2022Ali Ardakani, Novateur's Founder & Managing Director, serves as Chair of Life Sciences BC's Board of Directors. Life Sciences BC is the industry association supporting the growth and success of British Columbia's life sciences sector.
• Biotechnology Innovation Organization (BIO)coreGTM or Marketing Partner · 1 January 2020Partnership with BIO to co-brand and market the Guide to JPM/bioRSVP app for J.P. Morgan Healthcare Conference. BIO is the world's largest advocacy association for biosciences. The partnership expanded the app's global reach and credibility.
• IRICoRcoreStrategic or Co-development PartnerQuebec-based non-profit organization engaged Novateur experts for business development advisory, competitive landscape analysis, scientific due diligence, and market assessment. Novateur supported out-licensing of tumor-specific neo-antigen technology leading to Epitopea spin-out.
• adMare BioInnovationscoreStrategic or Co-development PartnerMajor Canadian biotech company engaged Novateur since 2018 for scientific due diligence, company creation support, regulatory strategy, reimbursement strategies, and business development. Work essential to creation of new Canadian life sciences companies.
• Université de Montréal / IRICminorStrategic or Co-development PartnerAcademic institution partnership through IRICoR for technology development and spin-out of Epitopea. Dr. Claude Perreault and Dr. Pierre Thibault's tumor-specific neo-antigen technology was developed at IRIC and exclusively licensed to Epitopea.
• Vitalli BiominorOthersUS biotechnology company founded by former Novartis executives (Joe Jimenez, Mark Fishman) that partnered with Daewoong Pharmaceutical through Novateur's facilitation for DWP213388 autoimmune drug candidate.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Lumanity: Global life sciences advisory firm providing commercialization, medical, and evidence consulting. Closely comparable in business model and customer base to Novateur, but at significantly greater scale.
• Beghou Consulting: Life sciences commercial consulting firm serving biotech and pharma with analytics, market access, and BD support. Directly comparable offering to Novateur's BD and commercialization advisory services.
• Trinity Life Sciences: Life sciences strategy and insights consultancy supporting biopharma commercialization, evidence, and BD. Comparable in services and client base to Novateur's advisory practice.
• Informa: Owns and operates the J.P. Morgan Healthcare Conference ecosystem and other major life sciences events. Direct comparator for Novateur's bioRSVP app and conference-driven GTM motion.

Broad incumbents

• ZS Associates: Large global management consulting firm with a substantial life sciences practice covering commercial strategy, R&D, and analytics. A broader incumbent competitor for advisory mandates.
• Charles River Associates: Global consulting firm with a Life Sciences practice providing economic, strategic, and regulatory advisory. Overlaps with Novateur's evidence, regulatory, and BD advisory work at greater scale.
• Syneos Health: Biopharma services firm offering clinical, commercial, and consulting solutions. Comparable in customer base and life sciences focus, though much larger and operationally broader than Novateur.

Others

• Biotechnology Innovation Organization (BIO): Largest life sciences industry advocacy organization and Novateur's strategic partner on bioRSVP. Adjacent rather than competitive, but the partnership defines Novateur's app distribution.
• Optigo Biotherapeutics: Biotherapeutics company co-founded by Novateur's founder Ali Ardakani. Directly tied to the founder rather than a market peer, but illustrative of Novateur's company-creation activities.

Emerging players

• CBR Pharma Insights: Pharma market intelligence and consulting firm providing BD support to biotechs. Comparable in advisory scope and target client segment to Novateur's deal advisory work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/NovateurBio
• LinkedInlinkedin.com/company/novateur-ventures-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novateur Ventures